StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
301237.SZ$66.28-3.24%
Fair $66.28+0.0%

301237.SZ

Hangzhou Heshun Technology Co.,LTD.

Basic Materials / Specialty ChemicalsShenzhen

$66.28

-2.22 (-3.24%)

Fairly Valued+0.0%Fair Value $66.28Fund rank 27/100 · Data gapFallback financials|
SA 32/D
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 23%

FCF escenarios

weak_data · normalized FCF $-289.1M · quality 67.0/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 33/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

32/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is -15.8%, below the 5% threshold
Thesis & Journal · 301237.SZLocal privado en este navegador · Hangzhou Heshun Technology Co.,LTD.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$5.3B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-15.8%

↓

Gross Margin

8.8%

↓

Debt/Equity

0.37

↑
52-Week Range$66
$25$81

TradingView lightweight chart

301237.SZ price, volumen y niveles de valoración

Último $66.28Periodo +23.9%
Fair value: $66.28

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+5.7%

FCF CAGR

—

FCF margin

-59.1%

FCF / Net income

1.94x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $595.4M · net income $-181.7M · FCF $-351.8M

2022-FY → 2025-FY

Gross margin

8.8%-11.0% pts

Operating margin

-1.3%-12.8% pts

Net margin

-30.5%-43.5% pts

FCF margin

-59.1%-23.8% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$595.4M$595.4M$503.1M$421.5M$503.5M
Net Income$-181.7M$-181.7M$-47.1M$14.6M$65.3M
EBITDA$-90.9M$-90.9M$10.8M$53.7M$106.7M
EPS-2.32-2.32-0.590.180.87
Gross Margin8.8%8.8%7.4%14.0%19.9%
Operating Margin-1.3%-1.3%-3.5%4.1%11.5%
Net Margin-30.5%-30.5%-9.4%3.5%13.0%
Balance Sheet
Debt/Equity0.370.370.100.050.03
Current Ratio2.972.97———
Cash Flow
Free Cash Flow$-351.8M$-351.8M$-289.1M$-266.2M$-177.7M
Returns
ROE-15.8%-15.8%-3.5%1.0%4.4%
Valuation
P/E———165.6135.40
EV/EBITDA——165.9542.2414.77
P/B4.524.521.281.691.54
Growth & Yield
Revenue Growth18.3%18.3%19.4%-16.3%—
EPS Growth-293.2%-293.2%-427.8%-79.3%—
Dividend Yield0.1%0.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +161.6%

Total return

+161.6%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.59 → -2.32

Residual

+161.5%

EPS growthn/d
Multiple reratingn/d
Dividend+0.1%
Residual / FX / buybacks / cross-term+161.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.